Article

ForbesForbes on 2021-12-16 14:49

Our Biopharma Industry Is A Critical National Security Asset, And Disarming It Before The Next Pandemic Is Folly

The most recent Covid-19 variant Omicron is a stark reminder that the threat posed by the next global virus presents a clear national security risk to ...

Related news